Comprehensive Evaluation of the Immune Risk Phenotype in Successfully Treated HIV-infected Individuals
Overview
Affiliations
Background: Despite successful treatment and CD4+ T-cell recovery, HIV-infected individuals often experience a profound immune dysregulation characterized by a persistently low CD4:CD8 T-cell ratio. This residual immune dysregulation is reminiscent of the Immune Risk Phenotype (IRP) previously associated with morbidity and mortality in the uninfected elderly (>85 years). The IRP consists of laboratory markers that include: a low CD4:CD8 T-cell ratio, an expansion of CD8+CD28- T-cells and cytomegalovirus (CMV) seropositivity. Despite the significant overlap in immunological phenotypes between normal aging and HIV infection, the IRP has never been evaluated in HIV-infected individuals. In this pilot study we characterized immune changes associated with the IRP in a sample of successfully treated HIV-infected subjects.
Methods: 18 virologically suppressed HIV-infected subjects were categorized into 2 groups based on their IRP status; HIV+IRP+, (n = 8) and HIV+IRP-, (n = 10) and compared to 15 age-matched HIV uninfected IRP negative controls. All individuals were assessed for functional and phenotypic immune characteristics including: pro-inflammatory cytokine production, antigen-specific proliferation capacity, replicative senescence, T-cell differentiation and lymphocyte telomere length.
Results: Compared to HIV-infected subjects without an IRP, HIV+IRP+ subjects exhibited a higher frequency of TNF-α-producing CD8+ T-cells (p = 0.05) and a reduced proportion of CD8+ naïve T-cells (p = 0.007). The IRP status was also associated with a marked up-regulation of the replicative senescence markers CD57 and KLGR1, on the surface of CD8+T-cells (p = 0.004). Finally, HIV+IRP+ individuals had a significantly shorter mean lymphocyte telomere length than their non-IRP counterparts (p = 0.03).
Conclusions: Our findings suggest that, despite similar levels of treatment-mediated viral suppression, the phenotypic and functional immune characteristics of HIV+IRP+ individuals are distinct from those observed in non-IRP individuals. The IRP appears to identify a subset of treated HIV-infected individuals with a higher degree of immune senescence.
Amino Acid Metabolism and Immune Dysfunction in Urea Cycle Disorders: T and B Cell Perspectives.
Karaaslan B, Kiykim A, Burtecene N, Gokden M, Cansever M, Hopurcuoglu D J Inherit Metab Dis. 2025; 48(2):e70009.
PMID: 39957310 PMC: 11831096. DOI: 10.1002/jimd.70009.
Silvera-Ruiz S, Gemperle C, Peano N, Olivero V, Becerra A, Haberle J Front Immunol. 2022; 13:861516.
PMID: 35711415 PMC: 9196877. DOI: 10.3389/fimmu.2022.861516.
Poloni C, Szyf M, Cheishvili D, Tsoukas C J Infect Dis. 2021; 225(3):443-452.
PMID: 34255838 PMC: 8344607. DOI: 10.1093/infdis/jiab365.
Poloni C, Tsoukas C Clin Infect Dis. 2020; 71(16):2306-2307.
PMID: 32496544 PMC: 7499531. DOI: 10.1093/cid/ciaa664.
Ramendra R, Isnard S, Lin J, Fombuena B, Ouyang J, Mehraj V Clin Infect Dis. 2019; 71(6):1438-1446.
PMID: 31608409 PMC: 7486843. DOI: 10.1093/cid/ciz1001.